Tango Therapeutics TNGX 深 沪
已收盘 10-30 16:00:00 美东时间
22.72
+0.190
+0.84%
华盛通- 最 高22.75
- 今 开22.11
- 成交量 527.93万股
- 最 低 21.71
- 昨 收 22.53
- 总市值 38.31亿
- 52周最高 34.39
- 市盈率 静 --
- 换手率 3.13%
- 52周最低 7.49
- 委 比 51.22%
- 总股本 1.69亿
- 历史最高 34.39
- 量 比 0.85
- 振 幅 4.62%
- 历史最低 1.03
- 每 手 1
- 风险率 7.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多医药行业10月裁员统计：裁员率最高达94%
进入年底，医药行业裁员消息密集释放。从跨国药企的全球降本计划，到 Biotech 因临床、商业化不及预期被动缩编，一起来看看本月行业裁员事件汇总。 10 月 ...
10-30 17:06
美股大行评级 | 潜在涨幅1112.12%！Canaccord Genuity上调Wave Life Sciences目标价至44美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences"买入"评级，目标价从42美元升至44美元；Canaccord Genuity：维持Pharming Group"买入"评级，目标价从38美元升至41美元
10-30 12:30
治疗“癌症之王”，明星RAS抑制剂组合再传捷报！
在今年的美国临床肿瘤学会（ASCO）年会上，Revolution Medicines开发的RAS抑制剂daraxonrasib凭借3期临床试验的积极结果，赢得全...
10-26 18:01
Tango Therapeutics shares are trading lower after the company announced results from its Phase 1/2 study of vopimetostat. A median PFS was not reached.
Tango Therapeutics shares are trading lower after the company announced results from its Phase 1/2 study of vopimetostat. A median PFS was not reached.
10-23 20:40
Tango Therapeutics To Present Updated Data From Phase 1/2 Study Of Vopimetostat In Combination With Daraxonrasib Or Zoldonrasib In Patients With MTAPdel/RASmut Metastatic PDAC And NSCLC At ESMO Congress 2026
Tango Therapeutics, Inc. (NASDAQ:TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that the Company will present updated data from a Phase 1/2 study of vopimetostat in combination with daraxonrasib...
10-16 19:05
Most shorted stocks on Wall Street
As October begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 39 stocks with short interest above 20% of...
10-05 21:35
美股牛股 | VKTX升近36%，给药频率减半仍维持97%减重；Vicor升逾19%，上调Q3营收指引
减肥药传来捷报！VKTX升近36%，给药频率减半仍维持97%减重；Vicor升逾19%，上调Q3营收指引；Grab Holdings升近9%，CEO增持近3000万美元股份>>
09-23 19:22
Caleres Posts Upbeat Q2 Earnings, Joins Opus Genetics, Flotek Industries And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Dow Jones index falling around 400 points on Wednesday. Shares of Caleres Inc (NYSE:CAL) rose sharply after the company reported better-than-expected second-quarter financial results and raised its FY26 EPS guidance. Caleres reported quarterly earnings of 47 cents pe...
09-09 22:04
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tango Therapeutics granted a new employee 146,500 stock options and 40,000 RSUs under its 2023 Inducement Plan. The options have an exercise price of $22.35 per share, vesting 25% after the first year and monthly thereafter, while RSUs vest annually over three years. The company focuses on precision cancer medicine using synthetic lethality principles.
09-03 20:05
Most shorted stocks on Wall Street
As September begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 44 stocks with short interest above 20% ...
09-02 22:28
